According to Cognitive Market Research, the global solid tumor testing market size is USD 24514.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
North America held the major market of more than 40% of the global revenue with a market size of USD 9805.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 7354.26 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 5638.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2031.
Latin America market of more than 5% of the global revenue with a market size of USD 1225.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.
Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 490.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2031.
The genetic testing held the highest solid tumor testing market revenue share in 2024.
